Two Sigma Advisers Reduces $40M in Cleveland-Cliffs Inc. ($CLF)
Key Points
- Two Sigma Advisers changed its Cleveland-Cliffs Inc. ($CLF) stake by 100.0% last quarter, cutting to 0 shares.
- Wall Street's consensus rating on $CLF is Hold and an average price target of $11.60.
- $CLF last traded around $13.71.
Two Sigma Advisers reduced its position in Cleveland-Cliffs Inc. ($CLF), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Cleveland-Cliffs Inc. after selling 2,908,928 shares during the quarter.
Cleveland-Cliffs Inc. ($CLF) Stock
Cleveland-Cliffs Inc. Earnings
Analysts Set New Price Targets
About Cleveland-Cliffs Inc.
Cleveland-Cliffs Inc. operates as a steel producer in the United States and Canada. It offers hot-rolled, cold-rolled, and coated products, such as aluminized, electrogalvanized, and galvalume products, as well as galvanneal and hot-dipped galvanized products; stainless and electrical products, including GOES, NOES, and auto chrome; plate products; and slab and other steel products. The company also provides non- steelmaking products comprising stamped components, tool and die, and tubing; and scrap, iron ore, HBI, coal, and coke products. It also provides tubular components, including carbon steel, stainless steel, and electric resistance welded tubing products. In addition, the company is involved in the mining of iron ore; production of pellets and direct reduced iron; and processing of ferrous scrap through primary steelmaking and downstream finishing, stamping, tooling, and tubing. It serves direct automotive, infrastructure and manufacturing, distributors and converters, and steel producers. The company was formerly known as Cliffs Natural Resources Inc. and changed its name to Cleveland-Cliffs Inc. in August 2017. Cleveland-Cliffs Inc. was founded in 1847 and is headquartered in Cleveland, Ohio.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.